- $16.45m
- $10.72m
Annual balance sheet for Polypid, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 26.6 | 44.5 | 32.2 | 12.6 | 5.31 |
| Net Total Receivables | 0.177 | — | 0.596 | 0.239 | 0.096 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 27.4 | 47.2 | 34.8 | 14.2 | 6.07 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.12 | 5.89 | 8.76 | 11.7 | 9.22 |
| Other Long Term Assets | |||||
| Total Assets | 33.8 | 75.8 | 44.2 | 26 | 15.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.58 | 2.88 | 8.08 | 8.55 | 7.29 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.1 | 3.07 | 8.28 | 20.1 | 17.5 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 18.7 | 72.8 | 36 | 5.83 | -2.1 |
| Total Liabilities & Shareholders' Equity | 33.8 | 75.8 | 44.2 | 26 | 15.4 |
| Total Common Shares Outstanding |